ROK Resources Inc (ROK.V) stock: key figures, P/E, revenue and dividend
Energy · Oil & Gas Exploration & Production · Canada · ISIN CA77544C1041
Price
0.31 CAD
Market cap
66.42 m CAD
P/E (2025)
–
P/S (2025)
0.97
Dividend yield
0.00 %
Net margin
-15.83 %
Return on equity (ROE)
-11.94 %
Return on assets (ROA)
-8.58 %
ROK Resources Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 85.19 m CAD | 68.18 m CAD |
| Gross profit | 47.42 m CAD | 37.72 m CAD |
| Operating income | -4.85 m CAD | -9.82 m CAD |
| EBIT | 1.12 m CAD | -13.88 m CAD |
| Net income | -636,000.00 CAD | -10.80 m CAD |
| Diluted EPS – continuing operations | -0.00 CAD | -0.05 CAD |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ROK Resources Inc
ROK Resources Inc. engages in oil and gas exploration and development in Canada. Its oil and gas assets are located in Southeast Saskatchewan and Kaybob Alberta. The company is headquartered in Regina, Canada.
More stocks
- JMC Electronics Co Ltd (6552.TW)
- Theradiag SA (ALTHE.PA)
- SM Culture & Contents Co. Ltd (048550.KQ)
- Bangkok Ranch PCL (BR.BK)
- Arizona Gold & Silver Inc. (AZS.V)
- CombinedX AB (CX.ST)
- Koryo Electronics Co Ltd (8032.TWO)
- VASO Corp (VASO)
- WESTWATER RESOURCES, INC. (WWR)
- Kentucky First Federal Bancorp (KFFB)
- TRANSACT TECHNOLOGIES INC (TACT)
- Advagene Biopharma Co. Ltd. (6709.TWO)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.